| Vybryon vs Eddy | 53–45 | 54.08% |
| Vybryon vs King | 51–41 | 55.43% |
| Vybryon vs Reina | 50–32 | 60.98% |
| Vybryon vs Kazuya | 44–29 | 60.27% |
| Vybryon vs Jin | 43–25 | 63.24% |
| Vybryon vs Steve | 38–27 | 58.46% |
| Vybryon vs Law | 33–26 | 55.93% |
| Vybryon vs Hwoarang | 27–32 | 45.76% |
| Vybryon vs Heihachi | 35–17 | 67.31% |
| Vybryon vs Bryan | 28–23 | 54.90% |
| Vybryon vs Lili | 34–11 | 75.56% |
| Vybryon vs Paul | 13–30 | 30.23% |
| Vybryon vs Devil Jin | 16–25 | 39.02% |
| Vybryon vs Asuka | 21–19 | 52.50% |
| Vybryon vs Lars | 18–21 | 46.15% |
| Vybryon vs Dragunov | 18–17 | 51.43% |
| Vybryon vs Feng | 12–18 | 40.00% |
| Vybryon vs Nina | 16–12 | 57.14% |
| Vybryon vs Azucena | 17–11 | 60.71% |
| Vybryon vs Lee | 10–17 | 37.04% |
| Vybryon vs Yoshimitsu | 16–9 | 64.00% |
| Vybryon vs Xiaoyu | 14–10 | 58.33% |
| Vybryon vs Alisa | 9–15 | 37.50% |
| Vybryon vs Victor | 10–14 | 41.67% |
| Vybryon vs Zafina | 13–7 | 65.00% |
| Vybryon vs Claudio | 8–11 | 42.11% |
| Vybryon vs Leo | 11–6 | 64.71% |
| Vybryon vs Jun | 9–8 | 52.94% |
| Vybryon vs Raven | 6–9 | 40.00% |
| Vybryon vs Lidia | 6–9 | 40.00% |
| Vybryon vs Jack-8 | 6–8 | 42.86% |
| Vybryon vs Leroy | 6–8 | 42.86% |
| Vybryon vs Clive | 3–4 | 42.86% |
| Vybryon vs Kuma | 3–2 | 60.00% |
| Vybryon vs Shaheen | 3–1 | 75.00% |
| Vybryon vs Fahkumram | 0–2 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.